This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages without signing in

Pathology

Authoring team

Inherited as an autosomal recessive disorder.

  • gene locus has been mapped to chromosome 11q - this was found to enclode a homologue of phosphatidylinositol 3-kinase which is involved in signal transduction between the cell surface and nucleus
  • the mechanism to how the genotype expresses the phenotype is unknown

Neuropathologically

  • this disease is characterized by cortical cerebellar degeneration
    • especially, there is a loss of Purkinje cell and granular cells from the cerebellar cortex

Notes:

  • exposure of cells to ionizing radiation gives rise to a range of lesions in DNA including potentially lethal double strand breaks - as a result of this damage a number of processes are initiated or activated including recognition of the lesions, recruitment of DNA repair proteins, signaling to cell cycle checkpoints, transcriptional activation and in some cases apoptotic death
    • the protein mutated in ataxia-telangiectasia, ATM, plays a central role in a number of these processes
    • ATM is rapidly activated by ionizing radiation

Reference:

  1. Furtado S et al. A review of the inherited ataxias: recent advances in genetic, clinical and neuropathologic aspects. Parkinsonism & Related Disorders; 4 (4):161-169.
  2. Lavin MF et al.Functional consequences of sequence alterations in the ATM gene. DNA Repair (Amst). 2004; 3(8-9):1197-205

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.